Dr. Bently Doonan, MD, MS

Claim this profile

University of Florida

Studies Skin Cancer
Studies Metastases
2 reported clinical trials
3 drugs studied

Area of expertise

1Skin Cancer
Bently Doonan, MD, MS has run 2 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Metastases
Bently Doonan, MD, MS has run 1 trial for Metastases. Some of their research focus areas include:
Stage IV

Affiliated Hospitals

Image of trial facility.
University Of Florida

Clinical Trials Bently Doonan, MD, MS is currently running

Image of trial facility.

CA-4948 + Pembrolizumab

for Melanoma

This phase I/II trial will investigate the use of the novel oral IRAK-4 inhibitor CA-4948 in combination with pembrolizumab therapy following stereotactic radiosurgery in patients with melanoma brain metastases (MBM). The investigators hypothesize that the addition of CA-4948 will reduce the rate of distant intracranial failure and reduce the need for subsequent radiation therapy. The investigators also propose that it will have a significant reduction in radiation necrosis and improve patient-reported symptoms and quality of life. This trial represents the first time an oral IRAK-4 inhibitor has been used in combination with aPD1 therapy in MBM and will yield valuable insight into its synergistic potential both in MBM and additional sites of metastases.
Recruiting1 award Phase 1 & 28 criteria

More about Bently Doonan, MD, MS

Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Bently Doonan, MD, MS has experience with
  • CA-4948
  • Pembrolizumab
  • Autologous Total Tumor MRNA Loaded DOTAP Liposome Vaccine
Breakdown of trials Bently Doonan, MD, MS has run
Skin Cancer
Metastases
Brain Cancer
Brain metastasis
Relapse

Other Doctors you might be interested in

Naykky Singh Ospina, MDUniversity of Florida
Thomas Beaver, MDShands at the University of Florida
Virginia ClarkUniversity of Florida College of Medicine

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bently Doonan, MD, MS specialize in?
Bently Doonan, MD, MS focuses on Skin Cancer and Metastases. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Bently Doonan, MD, MS currently recruiting for clinical trials?
Yes, Bently Doonan, MD, MS is currently recruiting for 1 clinical trial in Gainesville Florida. If you're interested in participating, you should apply.
Are there any treatments that Bently Doonan, MD, MS has studied deeply?
Yes, Bently Doonan, MD, MS has studied treatments such as CA-4948, Pembrolizumab, Autologous total tumor mRNA loaded DOTAP liposome vaccine.
What is the best way to schedule an appointment with Bently Doonan, MD, MS?
Apply for one of the trials that Bently Doonan, MD, MS is conducting.
What is the office address of Bently Doonan, MD, MS?
The office of Bently Doonan, MD, MS is located at: University of Florida, Gainesville, Florida 32608 United States. This is the address for their practice at the University of Florida.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top